Ufp Technologies (UFPT) Total Non-Current Liabilities (2010 - 2026)
Ufp Technologies (UFPT) posted Total Non-Current Liabilities of $234.0 million for Q1 2026, up 2.8% on a QoQ basis from $227.7 million in Q4 2025, and down 14.32% year-over-year from $273.2 million in Q1 2025.
Ufp Technologies (UFPT) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends
Ufp Technologies' Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $234.0 million for Q1 2026.
- Quarterly Total Non-Current Liabilities fell 14.32% year-over-year to $234.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $234.0 million (down 14.32% YoY) and the FY2025 annual result came in at $227.7 million, down 17.24% from the prior year.
- Total Non-Current Liabilities was $234.0 million for Q1 2026 at Ufp Technologies, up from $227.7 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $298.4 million in Q3 2024 and bottomed at $98.8 million in Q1 2024.
- A 5-year average of $182.0 million and a median of $153.1 million in 2022 frame the typical range for Total Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Non-Current Liabilities soared 529.29% — and 2023, when it plunged 34.44%.
- Ufp Technologies' Total Non-Current Liabilities stood at $131.1 million in 2022, then slipped by 16.12% to $109.9 million in 2023, then soared by 150.2% to $275.1 million in 2024, then slipped by 17.24% to $227.7 million in 2025, then advanced by 2.8% to $234.0 million in 2026.
- Business Quant data shows UFPT's Total Non-Current Liabilities at $234.0 million in Q1 2026, $227.7 million in Q4 2025, and $244.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | Ufp Technologies | 1.82 Bn | 1.80 Bn | 44.36 Mn | 234.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 234.05 Mn |
| Dec 31, 2025 | 227.68 Mn |
| Sep 30, 2025 | 244.63 Mn |
| Jun 30, 2025 | 245.00 Mn |
| Mar 31, 2025 | 273.15 Mn |
| Dec 31, 2024 | 275.09 Mn |
| Sep 30, 2024 | 298.42 Mn |
| Jun 30, 2024 | 102.46 Mn |
| Mar 31, 2024 | 98.84 Mn |
| Dec 31, 2023 | 109.95 Mn |
| Sep 30, 2023 | 112.39 Mn |
| Jun 30, 2023 | 123.12 Mn |
| Mar 31, 2023 | 131.88 Mn |
| Dec 31, 2022 | 131.08 Mn |
| Sep 30, 2022 | 153.08 Mn |
| Jun 30, 2022 | 187.79 Mn |
| Mar 31, 2022 | 144.71 Mn |
| Dec 31, 2021 | 134.50 Mn |
| Sep 30, 2021 | 28.86 Mn |
| Jun 30, 2021 | 29.84 Mn |